In Vitro Diagnostics (IVD) Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
January 18, 2022 07:00 ET
|
Graphical Research
Pune, India, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The global in vitro diagnostics (IVD) market size is estimated to witness lucrative growth during the forecast timeline owing to the rising...
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
January 10, 2022 08:00 ET
|
CVRx, Inc.
MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2
January 04, 2022 08:30 ET
|
ARCA biopharma, Inc.
Clinically important bradycardia is common in heart failure (HF) patients with persistent or paroxysmal atrial fibrillation (AF)In a Phase 2B clinical trial, the prevalence of clinically important...
Mesuron Inc. Announces Know-How License Agreement and Stock Purchase Agreement With Mayo Clinic
January 04, 2022 08:00 ET
|
Mesuron Inc.
LATHAM, N.Y., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Mesuron announced today that it has entered into a know-how collaboration agreement and stock purchase agreement with Mayo Clinic to further refine...
SoftWave Tissue Regeneration Technologies Enters Exclusive Distribution Agreement With Cynosure to Sell Technology in the Aesthetics and Sexual Health Markets
December 22, 2021 12:00 ET
|
Softwave TRT
ATLANTA, Dec. 22, 2021 (GLOBE NEWSWIRE) -- SoftWave Tissue Regeneration Technologies (SoftWave TRT) announced an exclusive agreement to supply Cynosure LLC, a global leader in medical aesthetics,...
前沿生物与AFFiRiS宣布就靶向PCSK9的高胆固醇血症治疗药物AFFITOPE®AT04达成大中华区许可协议
December 22, 2021 04:00 ET
|
AFFiRiS AG
前沿生物获得在大中华区开发与商业化AFFITOPE®AT04的独家权利合作旨在加快AFFITOPE®AT04主动免疫疗法作为同类首创新药的全球开发进程，推动其在大中华区的临床开发和生产落地 中国南京和奥地利维也纳, Dec. 22, 2021 (GLOBE NEWSWIRE) --...
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
December 22, 2021 04:00 ET
|
AFFiRiS AG
Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration accelerates the global development of AFFiRiS potential first-in-class...
CVRx to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Dec. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
Eko Named to the 2021 CB Insights Digital Health 150 List – Most Innovative Digital Health Startups
December 16, 2021 08:00 ET
|
Eko
OAKLAND, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Eko, a cardiopulmonary digital health company, has been named to the 2021 CB Insights Digital Health 150 list. The third annual ranking honors 150...
Radiofrequency Ablation Devices Market Size Worth $7,711.72 Million, Globally, by 2027 at 11.5% CAGR - Exclusive Report by The Insight Partners
December 16, 2021 07:41 ET
|
The Insight Partners
New York, Dec. 16, 2021 (GLOBE NEWSWIRE) -- According to the new market research report "Radiofrequency Ablation Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product...